Posted on April 30, 2015
The Asbestos Disease Awareness Organization (ADAO) is honored to be presenting at the 5th International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma on Saturday, May 2, 2015, in Santa Monica, California.This is ADAO’s fourth consecutive year presenting at the symposium, the only U.S. conference dedicated to lung-sparing therapies for mesothelioma, attended by renowned experts, surgeons, and clinical doctors from North America and Europe. The symposium will once again be chaired by Dr. Robert Cameron,Professor of Clinical Cardiothoracic Surgery, Surgical Oncology Director of the Comprehensive Mesothelioma Program at UCLA and Chief of Thoracic Surgery. Dr. Cameron spoke recently on “Surgical: Advancements and Challenges in Treating Mesothelioma” at the ADAO 11th Annual International Asbestos Awareness Conference. This year, ADAO President and Co-Founder, Linda Reinstein will be speaking on “The Human Cost of Inaction,” a presentation outlining asbestos consumption, asbestos-related disease and deaths, political and corporate chemical safety violations, significant and current legislation as well as relevant action techniques.
Below are a list of the riveting faculty that will be attending the conference.
Course Chair
- Robert B. Cameron, MD, FACS: Professor of Clinical Cardiothoracic Surgery and Surgical Oncology Director, Comprehensive Mesothelioma Program, David Geffen School of Medicine at UCLA; Chief, Thoracic Surgery; West Los Angeles VA Medical Center Los Angeles, California
International and Distinguished Faculty
- Marc de Perrot, MD, MSc: Associate Professor of Surgery, University of Toronto; Director, Toronto Mesothelioma Research Program; Division of Thoracic Surgery Toronto General Hospital Toronto, Canada
- J. Andrea McCart MD, MSc, FRCS(C): Associate Professor, Department of Surgery, University of Toronto Toronto General Research Institute
Faculty
- Clare Cameron: Executive Director, Pacific Heart, Lung, & Blood Institute Los Angeles, California
- Peter V. Chen, MD: Radiation Oncology, Hoag Family Cancer Institute Newport Beach, California
- Lien Hua-Feng, RN, MSN, NP-C: Nurse Practitioner, Pacific Mesothelioma Center, Pacific Heart, Lung, & Blood Institute Los Angeles, California
- Percy Lee, MD: Associate Professor, Chief, Thoracic Radiation Oncology, Director, Stereotactic Body Radiation Therapy Program, David Geffen School of Medicine at UCLA
- Shilpen Patel, MD, FACRO: Associate Professor, University of Washington Medical Center, Medical Director of the Clinical Outcomes Assessment Program/Foundation for Health Care Quality, Chief of Thoracic Radiation Oncology/Stereotactic Body Radiation Therapy Program Lead
- Walter Weder, MD: Professor of Surgery, Head, Division of Thoracic Surgery University Hospital of Zürich Zürich, Switzerland
- Mrs. Mia Lauter: Widow of Famed Actor Ed Lauter Los Angeles, California
- Olga Olevsky, MD: Health Sciences Assistant Clinical Professor Santa Monica Oncology, David Geffen School of Medicine at UCLA Santa Monica, California
- Linda Reinstein: President/CEO and Co-Founder Asbestos Disease Awareness Organization (ADAO)
- Raymond Wong, PhD: Research Scientist at the Pacific Meso Center, Pacific Heart, Lung, & Blood Institute Los Angeles, California
ADAO applauds Dr. Cameron and his colleagues at UCLA’s David Geffen School of Medicine for their continuing efforts to educate the medical community on the advancements in mesothelioma treatment.
In unity,
Linda
***
Dr. Robert B. Cameron is a board certified thoracic and general surgeon as well as a fully-trained surgical oncologist who serves as the Director of the UCLA and West LA VA Comprehensive Mesothelioma Programs as well as the Chief of Thoracic Surgery at the West Los Angeles VA. Dr. Cameron trained at UCLA, The National Cancer Institute of the National Institutes of Health as well as Memorial Sloan-Kettering Cancer Center and the Cornell-New York Hospital in New York. He has over 30 years of experience as a surgeon and over 20 as a specialist in mesothelioma. He has championed “lung-sparing” surgical techniques which over the last 10 years has become the preferred standard surgical procedure for mesothelioma throughout the world. Dr. Cameron is also interested in treating mesothelioma as a chronic disease through the use of cyroablation, immunotherapy, as well as mesenchymal stem cell and gene therapies.